Mercaptopurine

Mercaptopurine is a powerful medicine used to treat certain types of cancer, like leukemia. It works by stopping the body from making certain chemicals needed for cancer cells to grow. It's usually given as pills and often needs to be taken with other medicines. It's a strong chemotherapy drug.

Brand names:Puri-Nethol, Purinethol, Purixan
Medication

What people taking Mercaptopurine report

Every report comes from a Lived member, sent anonymously.

Have you tried Mercaptopurine for Acute Lymphoblastic Leukemia (ALL)?

NameHow it went

About Mercaptopurine

What It's For

Mercaptopurine, often called 6-MP, is a prescription medicine taken by mouth. Its approved use is in acute lymphoblastic leukemia (ALL), a cancer of the white blood cells that affects both children and adults. ALL treatment runs in phases, and mercaptopurine is part of the final maintenance phase, taken daily at home alongside other chemotherapy. It comes as generic 50 mg tablets and as Purixan, a liquid suspension that makes small, precise doses possible for children. Purinethol is an older brand name for the tablets. Doctors also prescribe mercaptopurine off label for Crohn's disease and ulcerative colitis, the two main forms of inflammatory bowel disease (IBD). Here it is used as an immune-calming medicine to keep the bowel in remission, sometimes together with a biologic medicine. This use is common but is not FDA approved, and the dose and goals differ from leukemia treatment.

How It Works

Mercaptopurine is a purine analog, a look-alike of the purine building blocks cells use to make DNA and RNA. Inside the body it is converted into active compounds called thioguanine nucleotides. These are built into the genetic material of dividing cells, which stops those cells from multiplying and causes them to die. Cells that divide quickly, such as leukemia cells and the immune cells that drive inflammation, are affected most, which is why the same medicine can treat a cancer and calm an overactive immune system. The body also breaks mercaptopurine down through two enzymes, TPMT (thiopurine methyltransferase) and NUDT15. Some people inherit genes that make one or both enzymes work poorly. Active drug then builds up, and a standard dose can act like an overdose on the bone marrow. This is the main reason the same dose affects people so differently.

Dosage & Administration

Mercaptopurine is usually taken once a day. The dose is based on body size and is then adjusted again and again according to blood counts, so it often changes during treatment. People with inherited low TPMT or NUDT15 activity may need a much smaller dose, and testing for these enzymes helps guide it. Lower starting doses are also used in kidney or liver disease. Food can reduce how much is absorbed, so the label advises taking it the same way each day, either always with food or always without. If a dose is missed, the label advises continuing with the next scheduled dose rather than doubling up. The tablets come in one strength, 50 mg, so a child under about 17 kg (37 pounds) generally cannot get an accurate dose from tablets, and anyone who cannot swallow tablets should not be given them. The Purixan liquid is shaken for at least 30 seconds and measured with the oral syringe supplied, and any liquid left 8 weeks after the bottle is opened is thrown away. Mercaptopurine is a hazardous drug, meaning it can harm people who are not taking it. The care team explains how to handle, store and dispose of it and how to clean up spills. It should be kept in its original container and out of reach of children.

Side Effects

The most important effect is lower blood counts. Fewer white blood cells raise the risk of infection, fewer red blood cells cause anemia (tiredness, pale skin, shortness of breath), and fewer platelets lead to easy bruising or bleeding. During leukemia maintenance some lowering is expected and intended, which is why regular blood tests drive the dose. Loss of appetite, nausea, vomiting, diarrhea, tiredness and rash affect a minority of people. The skin may burn more easily in the sun. Mercaptopurine can also damage the liver. This usually shows up in the first months but can appear much later, so liver blood tests are part of routine monitoring. In people taking it for IBD, inflammation of the pancreas (pancreatitis), which causes severe upper abdominal pain, is a recognized reaction. Call the care team right away for fever, chills, sore throat or other signs of infection; unusual bruising or bleeding; yellowing of the skin or eyes; swelling or pain in the upper right abdomen; or pale skin with weakness or breathlessness. People on leukemia treatment usually have specific instructions from their oncology team about fever, and those take priority.

Interactions & Warnings

Allopurinol, a gout medicine also used to prevent problems from rapid breakdown of cancer cells, blocks one of the routes the body uses to clear mercaptopurine. Taken together without a dose change, drug levels can rise to dangerous levels, so the mercaptopurine dose is cut to a third or a quarter. Other medicines that suppress the bone marrow add to the effect on blood counts, including aminosalicylates such as mesalamine and sulfasalazine, which are often used in IBD. Mercaptopurine can weaken the effect of warfarin, a blood thinner, so clotting tests may need closer checks. Because mercaptopurine suppresses the immune system, vaccines may work less well and live vaccines can cause infection, so vaccines should be planned with the care team. Long-term immune suppression also raises the risk of some cancers, notably skin cancers and lymphomas. A rare and aggressive lymphoma of the liver and spleen, hepatosplenic T-cell lymphoma, has been reported in people treated for IBD. Sun protection and skin checks are sensible during treatment. Mercaptopurine can harm a developing baby and raises the risk of miscarriage. The label advises effective contraception during treatment and for 6 months after the last dose for women who could become pregnant, and for 3 months after for men with a partner who could become pregnant. A pregnancy during treatment should be reported to the doctor right away. Breastfeeding is not advised during treatment or for 1 week after the last dose, and mercaptopurine can reduce fertility.

What to Expect

In leukemia, maintenance therapy means daily mercaptopurine at home, with other medicines given on a schedule, over a long stretch set by the treatment plan. Blood counts are checked frequently, and the dose goes up or down to keep white cell counts in a target range that balances leukemia control against infection risk. Liver tests are checked weekly at first and then about monthly. Taking doses as prescribed matters, because doing so during maintenance lowers the chance that the leukemia comes back. In IBD, mercaptopurine works slowly and is meant for keeping disease quiet over the long term rather than treating a flare quickly. Reviews of the trials suggest it helps more people stay in remission than no treatment, but the evidence is of low certainty and side effects lead some people to stop. Blood and liver tests continue for as long as it is taken. Whether to continue, or switch to another option such as a biologic, depends on how well the disease stays controlled and how the medicine is tolerated.

Questions to Ask Your Doctor

  1. 1.Have I been tested for TPMT and NUDT15, and how do the results affect my dose?
  2. 2.How often will my blood counts and liver tests be checked, and what results would lead to a dose change?
  3. 3.What should I do if I get a fever or signs of infection, and who do I call after hours?
  4. 4.Which of my other medicines, especially allopurinol, mesalamine or warfarin, need adjusting, and which vaccines are safe for me?
  5. 5.How long am I likely to take mercaptopurine, and what are the alternatives if it does not suit me?

Last reviewed • Oct 2026

Educational content, not medical advice.